ArticleInternal medicine (Tokyo, Japan)2017

Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis.

Masataka Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.